Copyright Reports & Markets. All rights reserved.

Global Pharmacokinetics Software Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Pharmacokinetics Software by Type
    • 1.3.1 Overview: Global Pharmacokinetics Software Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Pharmacokinetics Software Consumption Value Market Share by Type in 2025
    • 1.3.3 Compartmental Model
    • 1.3.4 Non-Compartmental Models
  • 1.4 Classification of Pharmacokinetics Software by Scene
    • 1.4.1 Overview: Global Pharmacokinetics Software Market Size by Scene: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Pharmacokinetics Software Consumption Value Market Share by Scene in 2025
    • 1.4.3 Drug Development
    • 1.4.4 Clinical
    • 1.4.5 Academic Teaching
  • 1.5 Classification of Pharmacokinetics Software by Deployment
    • 1.5.1 Overview: Global Pharmacokinetics Software Market Size by Deployment: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global Pharmacokinetics Software Consumption Value Market Share by Deployment in 2025
    • 1.5.3 Cloud-Based
    • 1.5.4 On-premises
  • 1.6 Global Pharmacokinetics Software Market by Application
    • 1.6.1 Overview: Global Pharmacokinetics Software Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Experimental Design
    • 1.6.3 Clinical Pharmacokinetics
    • 1.6.4 Other
  • 1.7 Global Pharmacokinetics Software Market Size & Forecast
  • 1.8 Global Pharmacokinetics Software Market Size and Forecast by Region
    • 1.8.1 Global Pharmacokinetics Software Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global Pharmacokinetics Software Market Size by Region, (2021-2032)
    • 1.8.3 North America Pharmacokinetics Software Market Size and Prospect (2021-2032)
    • 1.8.4 Europe Pharmacokinetics Software Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific Pharmacokinetics Software Market Size and Prospect (2021-2032)
    • 1.8.6 South America Pharmacokinetics Software Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa Pharmacokinetics Software Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Certara
    • 2.1.1 Certara Details
    • 2.1.2 Certara Major Business
    • 2.1.3 Certara Pharmacokinetics Software Product and Solutions
    • 2.1.4 Certara Pharmacokinetics Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Certara Recent Developments and Future Plans
  • 2.2 Simulations Plus
    • 2.2.1 Simulations Plus Details
    • 2.2.2 Simulations Plus Major Business
    • 2.2.3 Simulations Plus Pharmacokinetics Software Product and Solutions
    • 2.2.4 Simulations Plus Pharmacokinetics Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Simulations Plus Recent Developments and Future Plans
  • 2.3 IntiQuan GmbH
    • 2.3.1 IntiQuan GmbH Details
    • 2.3.2 IntiQuan GmbH Major Business
    • 2.3.3 IntiQuan GmbH Pharmacokinetics Software Product and Solutions
    • 2.3.4 IntiQuan GmbH Pharmacokinetics Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 IntiQuan GmbH Recent Developments and Future Plans
  • 2.4 Bayer
    • 2.4.1 Bayer Details
    • 2.4.2 Bayer Major Business
    • 2.4.3 Bayer Pharmacokinetics Software Product and Solutions
    • 2.4.4 Bayer Pharmacokinetics Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Bayer Recent Developments and Future Plans
  • 2.5 Genedata AG
    • 2.5.1 Genedata AG Details
    • 2.5.2 Genedata AG Major Business
    • 2.5.3 Genedata AG Pharmacokinetics Software Product and Solutions
    • 2.5.4 Genedata AG Pharmacokinetics Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Genedata AG Recent Developments and Future Plans
  • 2.6 Thermo Scientific
    • 2.6.1 Thermo Scientific Details
    • 2.6.2 Thermo Scientific Major Business
    • 2.6.3 Thermo Scientific Pharmacokinetics Software Product and Solutions
    • 2.6.4 Thermo Scientific Pharmacokinetics Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Thermo Scientific Recent Developments and Future Plans
  • 2.7 SGS
    • 2.7.1 SGS Details
    • 2.7.2 SGS Major Business
    • 2.7.3 SGS Pharmacokinetics Software Product and Solutions
    • 2.7.4 SGS Pharmacokinetics Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 SGS Recent Developments and Future Plans
  • 2.8 Pharmaron
    • 2.8.1 Pharmaron Details
    • 2.8.2 Pharmaron Major Business
    • 2.8.3 Pharmaron Pharmacokinetics Software Product and Solutions
    • 2.8.4 Pharmaron Pharmacokinetics Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Pharmaron Recent Developments and Future Plans
  • 2.9 Pumas-AI
    • 2.9.1 Pumas-AI Details
    • 2.9.2 Pumas-AI Major Business
    • 2.9.3 Pumas-AI Pharmacokinetics Software Product and Solutions
    • 2.9.4 Pumas-AI Pharmacokinetics Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Pumas-AI Recent Developments and Future Plans
  • 2.10 PharmoGo
    • 2.10.1 PharmoGo Details
    • 2.10.2 PharmoGo Major Business
    • 2.10.3 PharmoGo Pharmacokinetics Software Product and Solutions
    • 2.10.4 PharmoGo Pharmacokinetics Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 PharmoGo Recent Developments and Future Plans
  • 2.11 Chuangteng Technology
    • 2.11.1 Chuangteng Technology Details
    • 2.11.2 Chuangteng Technology Major Business
    • 2.11.3 Chuangteng Technology Pharmacokinetics Software Product and Solutions
    • 2.11.4 Chuangteng Technology Pharmacokinetics Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Chuangteng Technology Recent Developments and Future Plans
  • 2.12 Medixi Biomedical
    • 2.12.1 Medixi Biomedical Details
    • 2.12.2 Medixi Biomedical Major Business
    • 2.12.3 Medixi Biomedical Pharmacokinetics Software Product and Solutions
    • 2.12.4 Medixi Biomedical Pharmacokinetics Software Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Medixi Biomedical Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Pharmacokinetics Software Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Pharmacokinetics Software by Company Revenue
    • 3.2.2 Top 3 Pharmacokinetics Software Players Market Share in 2025
    • 3.2.3 Top 6 Pharmacokinetics Software Players Market Share in 2025
  • 3.3 Pharmacokinetics Software Market: Overall Company Footprint Analysis
    • 3.3.1 Pharmacokinetics Software Market: Region Footprint
    • 3.3.2 Pharmacokinetics Software Market: Company Product Type Footprint
    • 3.3.3 Pharmacokinetics Software Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Pharmacokinetics Software Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Pharmacokinetics Software Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Pharmacokinetics Software Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Pharmacokinetics Software Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Pharmacokinetics Software Consumption Value by Type (2021-2032)
  • 6.2 North America Pharmacokinetics Software Market Size by Application (2021-2032)
  • 6.3 North America Pharmacokinetics Software Market Size by Country
    • 6.3.1 North America Pharmacokinetics Software Consumption Value by Country (2021-2032)
    • 6.3.2 United States Pharmacokinetics Software Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Pharmacokinetics Software Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Pharmacokinetics Software Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Pharmacokinetics Software Consumption Value by Type (2021-2032)
  • 7.2 Europe Pharmacokinetics Software Consumption Value by Application (2021-2032)
  • 7.3 Europe Pharmacokinetics Software Market Size by Country
    • 7.3.1 Europe Pharmacokinetics Software Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Pharmacokinetics Software Market Size and Forecast (2021-2032)
    • 7.3.3 France Pharmacokinetics Software Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Pharmacokinetics Software Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Pharmacokinetics Software Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Pharmacokinetics Software Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Pharmacokinetics Software Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Pharmacokinetics Software Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Pharmacokinetics Software Market Size by Region
    • 8.3.1 Asia-Pacific Pharmacokinetics Software Consumption Value by Region (2021-2032)
    • 8.3.2 China Pharmacokinetics Software Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Pharmacokinetics Software Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Pharmacokinetics Software Market Size and Forecast (2021-2032)
    • 8.3.5 India Pharmacokinetics Software Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Pharmacokinetics Software Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Pharmacokinetics Software Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Pharmacokinetics Software Consumption Value by Type (2021-2032)
  • 9.2 South America Pharmacokinetics Software Consumption Value by Application (2021-2032)
  • 9.3 South America Pharmacokinetics Software Market Size by Country
    • 9.3.1 South America Pharmacokinetics Software Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Pharmacokinetics Software Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Pharmacokinetics Software Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Pharmacokinetics Software Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Pharmacokinetics Software Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Pharmacokinetics Software Market Size by Country
    • 10.3.1 Middle East & Africa Pharmacokinetics Software Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Pharmacokinetics Software Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Pharmacokinetics Software Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Pharmacokinetics Software Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Pharmacokinetics Software Market Drivers
  • 11.2 Pharmacokinetics Software Market Restraints
  • 11.3 Pharmacokinetics Software Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Pharmacokinetics Software Industry Chain
  • 12.2 Pharmacokinetics Software Upstream Analysis
  • 12.3 Pharmacokinetics Software Midstream Analysis
  • 12.4 Pharmacokinetics Software Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Pharmacokinetics Software market size was valued at US$ 544 million in 2025 and is forecast to a readjusted size of US$ 925 million by 2032 with a CAGR of 8.0% during review period.
    Pharmacokinetics Software is a type of professional software developed based on pharmacokinetic theory and computer algorithms. It is specifically used to process data related to the absorption, distribution, metabolism and excretion of drugs in organisms, and to realize functions such as parameter calculation, model building and process simulation. It provides data support and decision-making basis for drug development, clinical trials and personalized medicine.
    North America still dominates the global market, but the Asia-Pacific market is emerging at a faster growth rate. In 2023, North America was the largest revenue market in the field of pharmacokinetic computational biology, and in the life sciences software market, North America accounted for 42% of the market share in 2024, thanks to its mature innovative drug development system and the strong demand from numerous CRO companies.
    Policy adjustments by global regulatory agencies are continuously reshaping the development direction of pharmacokinetic software. The FDA's updated guidance in 2023 explicitly requires innovative drug applications to include physiologically based pharmacokinetic (PBPK) model data, and the EMA plans to implement an electronic submission system for ePK files by 2026. These policies are compelling pharmaceutical companies to adopt software with stronger compliance and better data management capabilities.
    This report is a detailed and comprehensive analysis for global Pharmacokinetics Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Pharmacokinetics Software market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Pharmacokinetics Software market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Pharmacokinetics Software market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Pharmacokinetics Software market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Pharmacokinetics Software
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Pharmacokinetics Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Certara, Simulations Plus, IntiQuan GmbH, Bayer, Genedata AG, Thermo Scientific, SGS, Pharmaron, Pumas-AI, PharmoGo, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Pharmacokinetics Software market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Compartmental Model
    Non-Compartmental Models
    Market segment by Scene
    Drug Development
    Clinical
    Academic Teaching
    Market segment by Deployment
    Cloud-Based
    On-premises
    Market segment by Application
    Experimental Design
    Clinical Pharmacokinetics
    Other
    Market segment by players, this report covers
    Certara
    Simulations Plus
    IntiQuan GmbH
    Bayer
    Genedata AG
    Thermo Scientific
    SGS
    Pharmaron
    Pumas-AI
    PharmoGo
    Chuangteng Technology
    Medixi Biomedical
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Pharmacokinetics Software product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Pharmacokinetics Software, with revenue, gross margin, and global market share of Pharmacokinetics Software from 2021 to 2026.
    Chapter 3, the Pharmacokinetics Software competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Pharmacokinetics Software market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmacokinetics Software.
    Chapter 13, to describe Pharmacokinetics Software research findings and conclusion.

    Buy now